Cipla

Junior Team Member - Microbiology

Cipla  •  Sikkim, IN (Onsite)  •  4 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Division

Department

Sub Department 1

Job Purpose

Execute analysis of allocated samples and Produce reliable and reproducible results in order to ensure their compliance to the microbiological quality parameters and predefined specifications and standards.

Key Accountabilities (1/6)

Analyse and review samples based on work allocation to meet the service level agreement

  • Analyse samples as per priority and work allocation
  • Review the data as per respective specification, Microbiological Methods and results obtained
  • Prepare, review and submit reports to Team leader within stipulated timelines in order to support individual sample release within stipulated timelines to achieve SLA

Key Accountabilities (2/6)

Report errors, abnormal observations, non-compliances related to procedures, equipment and instruments, and deliver results promptly to facilitate timely action and avoid delay in releases

  • Initiate investigations and take necessary corrective and preventive actions
  • Investigate incidence & lab error on priority basis so that batch release timely and issues are not recurring

Key Accountabilities (3/6)

Document entries, raw data and findings concomitantly in relevant test data sheets so as to facilitate the lab QA to review the reports and avoid missed entries

  • Review reports as per cGMP & GDP for compliance to GLP
  • Ensure no GMP / regulatory concern are raised by adhering to SOPs and following procedures

Key Accountabilities (4/6)

Evaluate & document Instrument / equipment break down and suggest mechanisms to avoid the same

Maintain equipment and instruments optimally to ensure no incidences or non-compliances occur due to malfunctioning of equipment/ instruments

Key Accountabilities (5/6)

Key Accountabilities (6/6)

Major Challenges

  • Availability of Validation records of analysis samples becomes a challenge in cases where validation is performed on other sites.
  • Material and resource availability becomes a challenge due to conflicting priorities between labs and coordination between analysts which makes it tough to fulfil SLA

Key Interactions (1/2)

Internal

  • Units for receiving specification, documents, protocols, area availability etc. (daily)
  • QA/QC for product sample release (daily)
  • Stores for procuring materials (need basis)
  • Communicate if any observation find on the specification.

Key Interactions (2/2)

External

CQA for procuring pharmacopial guidelines (need basis)

Dimensions (1/2)

  • Review and release approximate 15 MLT reports on daily basis to achieve the SLA.
  • Review and release approximately 15 sterility batches on weekly basis and 15 bio load samples.
  • 50 Water Samples analysis and release
  • 10 Technical Information Sheets for swap analysis
  • 6 Autoclave & DHS Operation
  • 200 locations released on daily basis for Environmental monitoring

Dimensions (2/2)

Key Decisions (1/2)

Recommendations

Daily Media and Plates requirement (to Team Leader Microbiology)

Key Decisions (2/2)

Education Qualification

M. Sc (Microbiology)

Relevant Work Experience

  • 1-5 years’ experience for analyst and 3-7 years for reviewer in Microbiology
  • Good knowledge of Microbiology, skill to perform assigned task, communication in English
Cipla

About Cipla

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years.

Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms.

Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients.

Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement.

An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Industry
Chemicals & Materials
Company Size
10,000+ employees
Headquarters
Mumbai, IN
Year Founded
Unknown
Website
cipla.com
Social Media